In this study, we examine the hypothesis that certain ADAM10 variants could increase the risk of AD by conferring earlier age-related downregulation of α-secretase, in opposition with other variants capable of maintaining high levels/activity of α-secretase at advanced ages. This evidence concerns the gene ADAM10 and Alzheimer disease.